John E. Davis - 14 Nov 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Reporting relationship: Chief Commercial Officer
Issuer ticker: AORT
Reported as of: 14 Nov 2025
Net transaction value: -$195,641
SEC form: 4
Accepted by SEC: 18 Nov 2025, 13:03:12 UTC
Prior SEC filing: 14 Nov 2025
Next SEC filing: 17 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ John E. Davis

Key filing fact

John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 18 Nov 2025.

Key facts

This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 18 Nov 2025, 13:03.

Change

Previous filing in this sequence was filed on 14 Nov 2025.
Current net transaction value: -$195,641.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001653206 Primary reporting owner

Davis John E

Relationship: Chief Commercial Officer
Address: 1655 ROBERTS BLVD., NW, KENNESAW
Signature: /s/ John E. Davis
Signature date: 18 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Options Exercise

Transaction value: $189,361
Shares: +6,393
Change %: +3.2%
Price: $29.62
Shares after: 205,235
Date: 14 Nov 2025
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $285,575
Shares: -6,393
Change %: -3.1%
Price: $44.67
Shares after: 198,842
Date: 14 Nov 2025
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Options Exercise

Transaction value: $189,390
Shares: +6,394
Change %: +3.2%
Price: $29.62
Shares after: 205,236
Date: 17 Nov 2025
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $288,817
Shares: -6,394
Change %: -3.1%
Price: $45.17
Shares after: 198,842
Date: 17 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AORT transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value: $0
Shares: -6,393
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 14 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,393
Exercise price: $29.62
Footnotes: F1, F2

AORT transaction Derivative

Stock Options (Right to buy)

Options Exercise

Transaction value: $0
Shares: -6,394
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 17 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,394
Exercise price: $29.62
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.

Footnote F2

Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.